Shareholder FOSUN PHARMA of SUNHERE plans to reduce its holdings by no more than 3%
I'm LongbridgeAI, I can summarize articles.According to the announcement from Zhitong Finance APP, SUNHERE announced that its shareholder Shanghai FOSUN PHARMA Industrial Development Co., Ltd. (hereinafter referred to as "FOSUN PHARMA"), holding 10.20% of the shares, plans to reduce its holdings of the company's shares by no more than 6.978 million shares, or no more than 3% of the company's total share capital, through centralized bidding and block trading within 90 days after 15 trading days from the date of the announcement (from March 18, 2025, to June 15, 2025)
According to the Zhitong Finance APP, SUNHERE (300452.SZ) announced that its shareholder Shanghai FOSUN PHARMA Industrial Development Co., Ltd. (hereinafter referred to as "FOSUN PHARMA"), holding 10.20% of the shares, plans to reduce its holdings of the company's shares by no more than 6.978 million shares, or no more than 3% of the company's total share capital, through centralized bidding and block trading within 90 days after the announcement, from March 18, 2025, to June 15, 2025
